Literature DB >> 28104735

Initial severity of depression and efficacy of cognitive-behavioural therapy: individual-participant data meta-analysis of pill-placebo-controlled trials.

Toshi A Furukawa1, Erica S Weitz2, Shiro Tanaka2, Steven D Hollon2, Stefan G Hofmann2, Gerhard Andersson2, Jos Twisk2, Robert J DeRubeis2, Sona Dimidjian2, Ulrich Hegerl2, Roland Mergl2, Robin B Jarrett2, Jeffrey R Vittengl2, Norio Watanabe2, Pim Cuijpers2.   

Abstract

BackgroundThe influence of baseline severity has been examined for antidepressant medications but has not been studied properly for cognitive-behavioural therapy (CBT) in comparison with pill placebo.AimsTo synthesise evidence regarding the influence of initial severity on efficacy of CBT from all randomised controlled trials (RCTs) in which CBT, in face-to-face individual or group format, was compared with pill-placebo control in adults with major depression.MethodA systematic review and an individual-participant data meta-analysis using mixed models that included trial effects as random effects. We used multiple imputation to handle missing data.ResultsWe identified five RCTs, and we were given access to individual-level data (n = 509) for all five. The analyses revealed that the difference in changes in Hamilton Rating Scale for Depression between CBT and pill placebo was not influenced by baseline severity (interaction P = 0.43). Removing the non-significant interaction term from the model, the difference between CBT and pill placebo was a standardised mean difference of -0.22 (95% CI -0.42 to -0.02, P = 0.03, I2 = 0%).ConclusionsPatients suffering from major depression can expect as much benefit from CBT across the wide range of baseline severity. This finding can help inform individualised treatment decisions by patients and their clinicians. © The Royal College of Psychiatrists 2017.

Entities:  

Mesh:

Year:  2017        PMID: 28104735      PMCID: PMC5331187          DOI: 10.1192/bjp.bp.116.187773

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  34 in total

1.  The need to consider the wider agenda in systematic reviews and meta-analyses: breadth, timing, and depth of the evidence.

Authors:  John P A Ioannidis; Fotini B Karassa
Journal:  BMJ       Date:  2010-09-13

2.  Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials.

Authors:  D Lynch; K R Laws; P J McKenna
Journal:  Psychol Med       Date:  2009-05-29       Impact factor: 7.723

Review 3.  Efficacy of cognitive-behavioural therapy and other psychological treatments for adult depression: meta-analytic study of publication bias.

Authors:  Pim Cuijpers; Filip Smit; Ernst Bohlmeijer; Steven D Hollon; Gerhard Andersson
Journal:  Br J Psychiatry       Date:  2010-03       Impact factor: 9.319

4.  Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.

Authors:  Lesley A Stewart; Mike Clarke; Maroeska Rovers; Richard D Riley; Mark Simmonds; Gavin Stewart; Jayne F Tierney
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

Review 5.  Antidepressant drug effects and depression severity: a patient-level meta-analysis.

Authors:  Jay C Fournier; Robert J DeRubeis; Steven D Hollon; Sona Dimidjian; Jay D Amsterdam; Richard C Shelton; Jan Fawcett
Journal:  JAMA       Date:  2010-01-06       Impact factor: 56.272

6.  Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm.

Authors:  Ulrich Hegerl; Martin Hautzinger; Roland Mergl; Ralf Kohnen; Michael Schütze; Winfried Scheunemann; Antje-Kathrin Allgaier; James Coyne; Verena Henkel
Journal:  Int J Neuropsychopharmacol       Date:  2009-04-03       Impact factor: 5.176

7.  Comparison of psychotherapies for adult depression to pill placebo control groups: a meta-analysis.

Authors:  P Cuijpers; E H Turner; D C Mohr; S G Hofmann; G Andersson; M Berking; J Coyne
Journal:  Psychol Med       Date:  2013-04-03       Impact factor: 7.723

8.  Selective publication of antidepressant trials and its influence on apparent efficacy.

Authors:  Erick H Turner; Annette M Matthews; Eftihia Linardatos; Robert A Tell; Robert Rosenthal
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

9.  Exploratory randomized controlled trial evaluating the impact of a waiting list control design.

Authors:  John A Cunningham; Kypros Kypri; Jim McCambridge
Journal:  BMC Med Res Methodol       Date:  2013-12-06       Impact factor: 4.615

Review 10.  Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis.

Authors:  Halle R Amick; Gerald Gartlehner; Bradley N Gaynes; Catherine Forneris; Gary N Asher; Laura C Morgan; Emmanuel Coker-Schwimmer; Erin Boland; Linda J Lux; Susan Gaylord; Carla Bann; Christiane Barbara Pierl; Kathleen N Lohr
Journal:  BMJ       Date:  2015-12-08
View more
  15 in total

1.  Possibly no baseline severity effect for antidepressants versus placebo but for antipsychotics. Why?

Authors:  Stefan Leucht; S Z Levine; M Samara; A Cipriani; J M Davis; T A Furukawa
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-10       Impact factor: 5.270

2.  A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression.

Authors:  Pim Cuijpers; Hisashi Noma; Eirini Karyotaki; Christiaan H Vinkers; Andrea Cipriani; Toshi A Furukawa
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

3.  The severity of psychiatric disorders.

Authors:  Mark Zimmerman; Theresa A Morgan; Kasey Stanton
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

4.  Cognitive and Behavioral Skills Exercises Completed by Patients with Major Depression During Smartphone Cognitive Behavioral Therapy: Secondary Analysis of a Randomized Controlled Trial.

Authors:  Toshi A Furukawa; Masaru Horikoshi; Hirokazu Fujita; Naohisa Tsujino; Ran Jinnin; Yuki Kako; Sei Ogawa; Hirotoshi Sato; Nobuki Kitagawa; Yoshihiro Shinagawa; Yoshio Ikeda; Hissei Imai; Aran Tajika; Yusuke Ogawa; Tatsuo Akechi; Mitsuhiko Yamada; Shinji Shimodera; Norio Watanabe; Masatoshi Inagaki; Akio Hasegawa
Journal:  JMIR Ment Health       Date:  2018-01-11

Review 5.  Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews.

Authors:  Gerald Gartlehner; Gernot Wagner; Nina Matyas; Viktoria Titscher; Judith Greimel; Linda Lux; Bradley N Gaynes; Meera Viswanathan; Sheila Patel; Kathleen N Lohr
Journal:  BMJ Open       Date:  2017-06-14       Impact factor: 2.692

6.  Trends in psychiatric diagnoses, medications and psychological therapies in a large Swedish region: a population-based study.

Authors:  T Forslund; K Kosidou; S Wicks; C Dalman
Journal:  BMC Psychiatry       Date:  2020-06-23       Impact factor: 3.630

Review 7.  Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations.

Authors:  Willemijn Scholten; Neeltje Batelaan; Anton Van Balkom
Journal:  Ther Adv Psychopharmacol       Date:  2020-06-10

8.  Dismantling, personalising and optimising internet cognitive-behavioural therapy for depression: a study protocol for individual participant data component network meta-analysis.

Authors:  Toshi A Furukawa; Eirini Karyotaki; Aya Suganuma; Alessandro Pompoli; Edoardo G Ostinelli; Andrea Cipriani; Pim Cuijpers; Orestis Efthimiou
Journal:  BMJ Open       Date:  2019-02-22       Impact factor: 2.692

9.  Smartphone Cognitive Behavioral Therapy as an Adjunct to Pharmacotherapy for Refractory Depression: Randomized Controlled Trial.

Authors:  Akio Mantani; Tadashi Kato; Toshi A Furukawa; Masaru Horikoshi; Hissei Imai; Takahiro Hiroe; Bun Chino; Tadashi Funayama; Naohiro Yonemoto; Qi Zhou; Nao Kawanishi
Journal:  J Med Internet Res       Date:  2017-11-03       Impact factor: 5.428

Review 10.  Assessment and Management of Cognitive and Psychosocial Dysfunctions in Patients With Major Depressive Disorder: A Clinical Review.

Authors:  Andrea Fiorillo; Bernardo Carpiniello; Serafino De Giorgi; Silvestro La Pia; Giuseppe Maina; Gaia Sampogna; Edoardo Spina; Alfonso Tortorella; Antonio Vita
Journal:  Front Psychiatry       Date:  2018-10-11       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.